Lipid Luminations

By ReachMD

What's Lipid Luminations about?

Get to the heart of the most recent advances in lipid management and cardiovascular disease with Lipid Luminations, which features scientific and clinical research updates, novel emerging treatment options, and best practices in patient care.

Download our free app to listen on your phone

Lipid Luminations episodes:

11.30.2018
Peripheral Artery Disease: How New Stent Options Are Revolutionizing Care
Host: Matt Birnholz, MD Guest: William Gray, MD When compared to the options available to coronary artery disease patients, advances in treatment for peripheral artery disease have unfortunately been lacking. But now that’s all changing with the introduction...
10.10.2016
Treating Erectile Dysfunction: Key Cardiovascular Considerations
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Robert Kloner, Vice President of...
10.03.2016
Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Rhoda Cooper-DeHoff. Dr. Cooper-DeHoff is...
09.26.2016
Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dave Dixon, PharmD, Clinical Pharmacist and...
09.19.2016
PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Eugenia Gianos. Dr. Gianos is...
06.20.2016
Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Patients in lipidolgy clinics sometimes undergo diagnostic workups for mild liver enzyme elevations, and in select cases a diagnosis of non-alcoholic fatty liver disease will be...
06.20.2016
Canadian Perspectives on Managing Lipid Disorders in Children
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Like in the United States, Canadian citizens contend with a high pediatric prevelance of lipid disorders, particularly familial hypercholesterolemia. However, perspectives on clinical care and standards...
06.08.2016
Lipid-Lowering Drug Interactions in Cardiovascular Agents
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Joining Dr. Alan Brown to discuss the pharmacokinetic data behind drug interactions between treatments for complex lipid abnormalities is Dr. Barbara Wiggins, Pharm.D, clinical pharmacy specialist...
06.06.2016
Selecting the Right Contraception for the Dyslipidemic Woman
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Robert Wild, MD, MPH, D.Phil. Recorded live at the recent Annual National Lipid Association meeting, Dr. Alan Brown welcomes Dr. Robert Wild to...
05.23.2016
Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross Host Dr. Alan Brown welcomes Joyce Ross, nurse practitioner and President of the National Lipid Association. Joyce is a consultative education...
05.16.2016
Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Dr. Seth Martin, cardiologist and assistant professor of medicine at the Johns Hopkins University School of Medicine with a joint appointment...
05.09.2016
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid...
05.02.2016
What's the Deal with Saturated Fat and Cardiovascular Disease Risk?
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Dr. Alan Brown welcomes Dr. Penny Kris-Etherton, Distinguished Professor of Nutrition at Penn State and Past President of NLA. Dr. Kris-Etherton reviews the current dietary recommendations...
04.21.2016
Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Dr. Steven Nissen, Chairman of the Department of Cardiovascular Medicine and Professor of Medicine at the Lerner School of Medicine of...
04.18.2016
The Lipidology Essentials: Making of a Specialty's Annual Summary
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Harold Bays, MD, FNLA Dr. Alan Brown welcomes Dr. Harold Bays, President of the Southeast Lipid Association and President of the Louisville Metabolic...
01.18.2016
Recognition and Management of Mental Illness for the Non-Psychiatric Clinician
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG Host Dr. Patrice Basanta Henry welcomes Dr Nzinga Harrison, Addiction Medicine & Psychiatrist, Campaign Psychiatrist for Let's Get Mentally Fit!, and, the CMO of ANKA Behavioral Health...
12.11.2015
Emerging Options for Elevated LDL Cholesterol: Focus on PCSK9 Inhibitors
Guest: Deepak Bhatt, MD, MPH High levels of low-density lipoprotein cholesterol (LDL-C) is the most common form of dyslipidemia and is a significant risk factor for CVD. Statin therapy has long been the mainstay for managing dyslipidemia; however, only 48%...
10.12.2015
The Life and Times of LDL Cholesterol
Host: Harold Bays, MD, FNLA Dr. Harold Bays welcomes Dr, Alan Remaley, clinical pathologist and Section Chief of the Lipoprotein Metabolism Section in the Cardiopulmonary Branch of the National Heart Lung, and Blood Institute...
09.21.2015
Clinical Decisions on Cardiovascular Disease: Are Risks or Causes Your Guide?
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Allan Sniderman, MD Risk is calculated by a variety of algorithms, all of which produce an estimate for that individual based on age,...
08.24.2015
Pathways Toward Better Lipid Medication Adherence
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Medication Adherence: is it the Achilles Heel in your therapies for patients with dyslipidemia? Dr. Lynne Braun, nurse practitioner in the Preventive Cardiology Center and the...
08.10.2015
Special Populations in Patient-Centered Management of Dyslipidemia
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Dr. Alan Brown welcomes Dr. Peter Jones, Associate Professor of Medicine and Atherosclorosis/Lipidology at Baylor College of Medicine in Houston, TX. They review special populations in...
08.03.2015
Updated NLA Recommendations for African American Patients
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA Host Dr. Alan Brown is joined by Dr. Keith C. Ferdinand, Professor at Tulane University...
07.27.2015
Dyslipidemia in The Elderly: How Old is "Too Old" to Treat?
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA One of the most recurrent questions that cardiologists and lipidologists face in daily practice is...
07.20.2015
Dyslipidemia in Children and Adolescents
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Dr. Don Wilson, Endocrinologist at Cook Children's Health Care System, Fort Worth, Texas. Dr. Wilson will review dyslipidemia in children and...
07.13.2015
Guidelines for Diagnosis and Management of Dyslipidemia in Patients with HIV
Host: Alan S. Brown, MD, FACC, FAHA, FNLA In this session of Lipid Luminations, host Dr. Alan Brown welcomes Dr. Merle Myerson, founder and director of the Cardiovascular Disease Prevention Program, Lipid Clinic, Pre-Exercise...
05.11.2015
Million Hearts Initiative with Dr. Janet Wright, Executive Director
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Janet Wright, MD Heart disease and stroke are two of the leading causes of death in the United States. The Department of Health...
09.22.2014
Dyslipidemia During Pregnancy: The Risks for Two Patients
Host: Alan S. Brown, MD, FACC, FAHA, FNLA An old clinical dogma in OB/GYN was that dyslipidemia during pregnancy wouldn't have any long term implications on the developing fetus because of short exposures at...
09.22.2014
Statin Intolerance: Keys to Patient Counseling and Guidance
Host: Alan S. Brown, MD, FACC, FAHA, FNLA As many as 25% of patients taking statins may experience side effects. How should clinicians respond to the broad spectrum of side effects and variable severities...
09.16.2014
Roles of Non-HDL Cholesterol in Risk Assessment and Treatment
Host: Alan S. Brown, MD, FACC, FAHA, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the...
09.15.2014
Roles of Non-HDL Cholesterol in Risk Assessment and Treatment
Host: Alan S. Brown, MD, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the clinical dogma once focused on targeting specific lipoproteins,...
09.09.2014
Keys to the Latest NLA Recommendations for Dyslipidemia Treatments
Host: Alan S. Brown, MD, FACC, FAHA, FNLA What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all...
08.26.2014
Management of the Patient With Triglycerides 200-499 mg/dl.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Carl Orringer, MD, FACC, FNLA What are some of the causes of high triglycerides? What is the biggest health risk? And, for these...
05.13.2014
What is the Safety of Statins in Patients with Diabetes?
Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FACC, FAHA, FNLA At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD,...
05.13.2014
A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines
Guest: Anne Goldberg, MD Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown is joined by Anne Goldberg, MD, Associate Professor of Medicine at Washington University School of Medicine...
05.08.2014
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia
Guest: Kevin C. Maki, PhD, FNLA, CLS Guest: Carl Orringer, MD, FACC, FNLA Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Matthew Ito, PharmD, FNLA ...
01.08.2014
New Insights on Statin Therapy for Older Patients
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Is there a patient age at which statin therapy should be discontinued? Likewise, what does the current evidence tell us about initiating vs not initiating statin...
01.07.2014
HPS-2 THRIVE Data and Results
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Joining host Dr. Alan Brown is Dr. John Guyton, Associate Professor of Medicine and Assistant Professor of Pathology of the Division of Medicine-Endocrinology and Metabolism at Duke...
12.17.2013
Health Information Technology's Impact on Adherence to Lipid Therapy
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Health information technologies have evolved dramatically from simplistic documentation devices early on to sophisticated drivers of quality patient care today. This emergence is having a particularly...
10.29.2013
Cardiometabolic Consequences of Sitting Time
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Dr. Marc Hamilton, Professor at Pennington Biomedical Research Center in Baton Rouge, LA. Their convesation focuses on the cardiometabolic consequences of lengthy...
10.29.2013
Generics and Manufacturing: What Prescribers Need to Know
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Joining host Dr. Alan Brown is Michael B. Bottorff, Pharm.D., Professor and Chair in the Department of Pharmacy Practice at South College School of Pharmacy in...
10.21.2013
Genetic Testing for Familial Hypercholesterolemia
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Speaking with host Dr. Alan Brown on the state of genetic testing for familial hypercholesterolemia (FH) is Dr. Joshua W. Knowles, MD, PhD, Instructor of Cardiovascular...
10.09.2013
Research Updates in Familial Hypercholesterolemia
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Dr. Alan Brown is joined by Dr. Bart Duell, director of the Lipid Disorders Clinic at the Oregon Health and Sciences University and one of the top...
09.23.2013
Research Updates on Postprandial Dyslipidemia Treatment
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Postprandial hypertriglyceridemia occurs when the rapid absorption of dietary fat (in the form of chylomicron triglycerides) overwhelms the body's ability to clear plasma triglyceride. In its...
09.23.2013
Lipid Biomarker Updates: When to Move Beyond the Standard Profile
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Dr. Alan Brown is joined by Dr. Thomas Dayspring, Director of Cardiovascular Education for the Foundation for Health Improvement and Technology in Richmond, VA and clinical...
08.28.2013
What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Patient
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Dr. Alan Brown welcomes Dr. Daniel J. Rader, Cooper-McLure Professor of Medicine and Pharmacology and Chief of the Division of Translational Medicine and Human Genetics at...
08.21.2013
Adiposity, Obesity, and Dyslipidemia
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Dr. Harold Bays, Chair for the National Lipid Association's expert panel on Adiposity, Obesity, and Dyslipidemia, discusses with host Dr. Alan Brown the panel's consensus statement...
08.12.2013
Researching Oxidized High-Density Lipoprotein in Obese Adolescents
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Obesity is associated with systemic inflammation and oxidative stress, the leading steps towards development of atherosclerosis. Myloperoxidase (MPO) mediated oxidative damage of high-density lipoprotein (HDL) leads...
07.09.2013
Underrecognition of Diabetes in Cardiology Practice
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Joining Dr. Alan Brown is Revathi Balakrishnan, MD, MPH, a general cardiology fellow at NYU and winner of the NLA Young Investigator Competition. Dr. Balakrishnan's research,...
06.19.2013
An Avocado a Day: Does It Keep Heart Disease Away?
Host: Alan S. Brown, MD, FACC, FAHA, FNLA There may be something unique about the avocado, far beyond its monosaturated fat content. Li Wang, graduate student at Penn State University and winner of the...
06.11.2013
The Impact of Inflammation on HDL Activity
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown is joined by David Tehrani, MS, a medical student at the University of California - Irvine School of Medicine and winner of...

What's Lipid Luminations about?

Download our free app to listen on your phone

Lipid Luminations episodes:

Peripheral Artery Disease: How New Stent Options Are Revolutionizing Care

Treating Erectile Dysfunction: Key Cardiovascular Considerations

Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?

Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines

PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects

Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease

Canadian Perspectives on Managing Lipid Disorders in Children

Lipid-Lowering Drug Interactions in Cardiovascular Agents

Selecting the Right Contraception for the Dyslipidemic Woman

Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross

Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide

Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies

What's the Deal with Saturated Fat and Cardiovascular Disease Risk?

Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines

The Lipidology Essentials: Making of a Specialty's Annual Summary

Recognition and Management of Mental Illness for the Non-Psychiatric Clinician

Emerging Options for Elevated LDL Cholesterol: Focus on PCSK9 Inhibitors

The Life and Times of LDL Cholesterol

Clinical Decisions on Cardiovascular Disease: Are Risks or Causes Your Guide?

Pathways Toward Better Lipid Medication Adherence

Special Populations in Patient-Centered Management of Dyslipidemia

Updated NLA Recommendations for African American Patients

Dyslipidemia in The Elderly: How Old is "Too Old" to Treat?

Dyslipidemia in Children and Adolescents

Guidelines for Diagnosis and Management of Dyslipidemia in Patients with HIV

Million Hearts Initiative with Dr. Janet Wright, Executive Director

Dyslipidemia During Pregnancy: The Risks for Two Patients

Statin Intolerance: Keys to Patient Counseling and Guidance

Roles of Non-HDL Cholesterol in Risk Assessment and Treatment

Roles of Non-HDL Cholesterol in Risk Assessment and Treatment

Keys to the Latest NLA Recommendations for Dyslipidemia Treatments

Management of the Patient With Triglycerides 200-499 mg/dl.

What is the Safety of Statins in Patients with Diabetes?

A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia

New Insights on Statin Therapy for Older Patients

HPS-2 THRIVE Data and Results

Health Information Technology's Impact on Adherence to Lipid Therapy

Cardiometabolic Consequences of Sitting Time

Generics and Manufacturing: What Prescribers Need to Know

Genetic Testing for Familial Hypercholesterolemia

Research Updates in Familial Hypercholesterolemia

Research Updates on Postprandial Dyslipidemia Treatment

Lipid Biomarker Updates: When to Move Beyond the Standard Profile

What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Patient

Adiposity, Obesity, and Dyslipidemia

Researching Oxidized High-Density Lipoprotein in Obese Adolescents

Underrecognition of Diabetes in Cardiology Practice

An Avocado a Day: Does It Keep Heart Disease Away?

The Impact of Inflammation on HDL Activity